A very recent study (76) reported in details the stepwise changes in glycosylation of A1AT progressing from liver cirrhosis to cancer and identified a core fucosylation on A1AT as a HCC specific modification. The gene discussed is SERPINA1; the disease is hepatocellular carcinoma.